Recent studies indicate that on one hand, severely elevated CRP and ferritin can worsen clinical outcomes in COVID-19 (Caricchio et al., 2021), and on the other hand, a decrease of inflammation parameters throughout the clinical course reduces the risk of development and severity of ARDS (Wu et al., 2020). Here, CRP is linked to COVID-19.